Article by David George-Cosh, BNN Bloomberg
A number of chief executives in the cannabis industry seem to have one surprising thing in common: They don’t like to get high on their own supply.
BNN Bloomberg conducted a survey of more than two dozen CEOs running U.S. and Canadian cannabis firms, ranging from some of Canada’s biggest pot companies to billion-dollar U.S. operators, to learn whether they actually use the product their pushing.
Of the 29 CEOs polled, 17 executives said they use cannabis recreationally or for medical purposes, while six said they did not use marijuana. Another six CEOs declined to comment despite repeated assurances their responses will be kept anonymous. All respondents were offered the cover of anonymity to prevent potential future legal issues, but were also given the opportunity to speak on-the-record to describe their personal usage.
While the survey does not represent the total number of executives running pot producers throughout North America, it does show that a significant number of CEOs who run these cannabis firms are abstaining from the drug or are not willing to come clean with their views on usage.
“What I have come to understand is that cannabis consumers are an extremely diverse group,” said Sebastien St-Louis, chief executive of Quebec-based Hexo Corp., in an email interview with BNN Bloomberg. He said he uses cannabis recreationally on Friday nights to “cap off the week.”